1J5 — Hyphens Pharma International Share News
0.000.00%
Last trade - 00:00- SG$108.10m
- SG$93.21m
- SG$177.37m
Brief: Hyphens Pharma International Says Unit Gets Exclusive Rights To Commercialise Metoject
Brief: Hyphens Pharma International Posts FY Net Income Of SGD 10.9 Million
Brief: Hyphens Pharma International Licenses Amenalief From Maruho For ASEAN
Brief: Hyphens Pharma International Posts Net Profit After Tax In 1Q2024 S$2.7 Million
Brief: Hyphens Pharma International Says Unit Entered Exclusive License, Supply Deal
Brief: Hyphens Pharma International Says Co's Ceradan Range Of Products To Enter Middle East Markets
Brief: Hyphens Pharma International Declares Final Dividend Of 0.86 Singapore Cents Per Share
Brief: Hyphens Pharma International Says Collaboration With 7-Eleven Singapore
Brief: Hyphens Pharma International Proposes Acquisition Of 58% Of Share Capital In Ardence Pharma
Brief: Hyphens Pharma International Announces Appointment Of Chief Financial Officer
Brief: Hyphens Pharma International To Develop, Commercialise Byfavo Procedural Sedation Drug In Singapore
Brief: Hyphens Pharma International Posts Qtrly Profit, Net Of Tax Of S$1.4 Million
Brief: Hyphens Pharma International Proposes First And Final Dividend Of 1.11 SG Cents
Brief: Hyphens Pharma International Says Unit Entered Into License And Supply Agreements
Brief: Hyphens Pharma International Posts Qtrly Profit After Tax S$4.0 Million
Brief: Hyphens Pharma International Records HY Profit After Tax S$6.2 Mln
Brief: Hyphens Pharma International Attracts S$6 Mln Investment In Docmed Technology
Brief: Hyphens Pharma International Announces Resignation Of Chief Financial Officer
Brief: Hyphens Pharma International Says It Entered Collaboration With Servier Singapore